Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barbieri

Showing results (231-240 of 305) with videos related to

Pageof 31
Sort By:
Genome Biology|May 4, 2017
Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrationsDavide Prandi, Sylvan C Baca, Alessandro Romanel, et al.
The Journal of Urology|September 28, 2011
Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent mannerShahrokh F Shariat, Thomas F Chromecki, Julia Hoefer, et al.
ESMO Open|April 7, 2023
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)L Cortesi, M Venturelli, G Cortesi, et al.
The Journal of Urology|July 28, 2022
Impact of Left-Digit Age Bias in the Treatment of Localized Prostate CancerAaron Brant, Patrick Lewicki, Xian Wu, et al.
Translational Oncology|December 23, 2019
Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell CarcinomaJohannes C van der Mijn, Leiping Fu, Francesca Khani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trialS Frustaci, F Gherlinzoni, A De Paoli, et al.
BJU International|August 20, 2011
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trialChristopher E Barbieri, Eugene K Cha, Thomas F Chromecki, et al.
Frontiers in Oncology|June 14, 2021
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate CancerSpyridon P Basourakos, Michael Tzeng, Patrick J Lewicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2014
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatmentJacqueline Fontugne, Daniel Lee, Chiara Cantaloni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Evidence for molecular differences in prostate cancer between African American and Caucasian menFrancesca Khani, Juan Miguel Mosquera, Kyung Park, et al.
Pageof 31

Showing results (231-240 of 305) with videos related to

Sort By:
Pageof 31
Genome Biology|May 4, 2017
Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrationsDavide Prandi, Sylvan C Baca, Alessandro Romanel, et al.
The Journal of Urology|September 28, 2011
Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent mannerShahrokh F Shariat, Thomas F Chromecki, Julia Hoefer, et al.
ESMO Open|April 7, 2023
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)L Cortesi, M Venturelli, G Cortesi, et al.
The Journal of Urology|July 28, 2022
Impact of Left-Digit Age Bias in the Treatment of Localized Prostate CancerAaron Brant, Patrick Lewicki, Xian Wu, et al.
Translational Oncology|December 23, 2019
Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell CarcinomaJohannes C van der Mijn, Leiping Fu, Francesca Khani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trialS Frustaci, F Gherlinzoni, A De Paoli, et al.
BJU International|August 20, 2011
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trialChristopher E Barbieri, Eugene K Cha, Thomas F Chromecki, et al.
Frontiers in Oncology|June 14, 2021
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate CancerSpyridon P Basourakos, Michael Tzeng, Patrick J Lewicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2014
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatmentJacqueline Fontugne, Daniel Lee, Chiara Cantaloni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Evidence for molecular differences in prostate cancer between African American and Caucasian menFrancesca Khani, Juan Miguel Mosquera, Kyung Park, et al.
Pageof 31